Assembly Biosciences Inc.

NASDAQ: ASMBHealthcare / Drug Manufacturers - Major / USA
12.90-0.2200-1.68%Vol 251 5751Y Perf -70.85%
Jun 24th, 2019 16:00
BID1.00 ASK21.00
Open13.13 Previous Close13.12
Pre-Market- After-Trading12.90
 - -%  - -%
Target Price
44.00 
Analyst Rating
Strong Buy 1.40
Potencial %
241.09 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/-20 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/-74 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/-75 
Income Ranking
 —    -
Market Cap (mil)330 
Earnings Rating
Buy
Price Range Ratio 52wk %
0.47 
Earnings Date
14th Aug 2019

Today's Price Range

12.7513.29

52wk Range

12.7544.65

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
-15.14%
3 Months
-27.91%
6 Months
-32.23%
1 Year
-70.85%
3 Years
133.45%
5 Years
87.43%

Name / TickerPriceChg.Chg.%
ASMB12.90-0.2200-1.68
AAPL198.58-0.2000-0.10
GOOG1 115.52-6.3600-0.57
MSFT137.780.81000.59
XOM76.95-0.7400-0.95
WFC46.27-0.6200-1.32
JNJ143.060.97000.68
FB192.601.46000.76
GE10.28-0.2000-1.91
JPM108.66-0.7800-0.71
Earnings HistoryEstimateReportedSurprise %
Q01 2019-1.07-1.051.87
Q04 2018-0.91-1.03-13.19
Q03 2018-1.02-0.8714.71
Q02 2018-0.90-1.30-44.44
Q01 2018-0.76-0.80-5.26
Q04 2017--0.16-
Q03 2017-0.88-0.7119.32
Q01 2017-0.03-0.81-2 600.00
Earnings Per EndEstimateRevision %Trend
6/2019 QR-1.101.79Positive
9/2019 QR-1.132.59Positive
12/2019 FY-4.345.86Positive
12/2020 FY-4.6510.23Positive
Next Report Date14th Aug 2019
Estimated EPS Next Report-1.10
Estimates Count4
EPS Growth Next 5 Years %-
Volume Overview
Volume251 575
Shares Outstanding (in ths.)25 550
Trades Count1 484
Dollar Volume2 571 062
Avg. Volume277 141
Avg. Weekly Volume379 376
Avg. Monthly Volume200 569
Avg. Quarterly Volume304 754
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (80.00 %)
4 (80.00 %)
4 (80.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (20.00 %)
1 (20.00 %)
1 (20.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.40
Strong Buy
1.40
Strong Buy
1.40

Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical stage biotechnology company. It is advancing two innovative platform programs, a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein.

CEO: Derek A. Small

Teplephone: +1 317 210-9311

Address: 11711 North Meridian Street, Carmel 46032, IN, USA

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

25%75%

Bearish Bullish

50%50%

Bearish Bullish

50%50%

News